biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Feb 18, 2017 10:35am

184 Views

Post# 25865241

RE:kayacker...just a question??

but wasnt our bti share price cut in half too by the end of 2016?..i could have swore we hit 2.05$ at some point last year before our first 20million$ deal???
i think we closed around a buck if i am not mistaken?

You do realize that would only make sense if the bet was offered at the same time BTI peaked above $2?

The bet (where I had to fly myself to Calgary if I won, LOL)
April 5th. BTI closed at 1.40.
Dec 31st, BTI closed at 1.07.

Menika Mining (MML), April 5th, closed at 50¢.
Changed it's name to American Lithium (LI), closed Dec 31st at 19¢.

Happy now?

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!